Global Generic Injectables Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Executive Summary
According to GRD Survey data, the global Generic Injectables market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Generic Injectables market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Generic Injectables in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Small Molecule
Large Molecule
Market Snapshot, By Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Teva Pharmaceutical
Sanofi
Sandoz (Novartis)
Nichi-Iko Group (Sagent)
Hospira (Pfizer Inc.)
Hikma Pharmaceuticals PLC
Grifols
Gland Pharma
Fresenius Kabi
Endo International PLC
Dr. Reddy's Laboratories Ltd
Auromedics
The study objectives of this report are:
To study and analyze the global Generic Injectables market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Generic Injectables market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Generic Injectables manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Generic Injectables market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Generic Injectables submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Generic Injectables are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Generic Injectables Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Generic Injectables Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Generic Injectables
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Application One
3.2.2 Major Buyers in Application Two
3.2.1 Major Buyers in Application Three
4 Market Segment: by Type
4.1 Generic Injectables Type Introduction
4.1.1 Small Molecule
4.1.2 Large Molecule
4.2 Global Generic Injectables Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 Generic Injectables Type Introduction
5.1.1 Oncology
5.1.2 Anesthesia
5.1.3 Anti-Infectives
5.1.3 Parenteral Nutrition
5.1.4 Cardiovascular Diseases
5.2 Global Generic Injectables Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Generic Injectables Market by Region
6.2 North America Generic Injectables Market 2016-2021
6.3 Europe Generic Injectables Market 2016-2021
6.4 Asia Pacific Generic Injectables Market 2016-2021
6.5 South America Generic Injectables Market 2016-2021
6.6 Middle East and Africa Generic Injectables Market 2016-2021
7 North America
7.1 North America Generic Injectables Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Generic Injectables Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Generic Injectables Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Generic Injectables Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Generic Injectables Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
3.1 Teva Pharmaceutical
3.1.1 Teva Pharmaceutical Company Information
3.1.2 Teva Pharmaceutical Generic Injectables Product Portfolio, Specification and Application
3.1.3 Teva Pharmaceutical Generic Injectables Revenue and Gross Margin (2019-2021)
3.1.4 Teva Pharmaceutical Key Development
3.2 Sanofi
3.2.1 Sanofi Company Information
3.2.2 Sanofi Generic Injectables Product Portfolio, Specification and Application
3.2.3 Sanofi Generic Injectables Revenue and Gross Margin (2019-2021)
3.2.4 Sanofi Key Development
3.3 Sandoz (Novartis)
3.3.1 Sandoz (Novartis) Company Information
3.3.2 Sandoz (Novartis) Generic Injectables Product Portfolio, Specification and Application
3.3.3 Sandoz (Novartis) Generic Injectables Revenue and Gross Margin (2019-2021)
3.3.4 Sandoz (Novartis) Key Development
3.4 Nichi-Iko Group (Sagent)
3.4.1 Nichi-Iko Group (Sagent) Company Information
3.4.2 Nichi-Iko Group (Sagent) Generic Injectables Product Portfolio, Specification and Application
3.4.3 Nichi-Iko Group (Sagent) Generic Injectables Revenue and Gross Margin (2019-2021)
3.4.4 Nichi-Iko Group (Sagent) Key Development
3.5 Hospira (Pfizer Inc.)
3.5.1 Hospira (Pfizer Inc.) Company Information
3.5.2 Hospira (Pfizer Inc.) Generic Injectables Product Portfolio, Specification and Application
3.5.3 Hospira (Pfizer Inc.) Generic Injectables Revenue and Gross Margin (2019-2021)
3.5.4 Hospira (Pfizer Inc.) Key Development
3.6 Hikma Pharmaceuticals PLC
3.6.1 Hikma Pharmaceuticals PLC Company Information
3.6.2 Hikma Pharmaceuticals PLC Generic Injectables Product Portfolio, Specification and Application
3.6.3 Hikma Pharmaceuticals PLC Generic Injectables Revenue and Gross Margin (2019-2021)
3.6.4 Hikma Pharmaceuticals PLC Key Development
3.7 Grifols
3.7.1 Grifols Company Information
3.7.2 Grifols Generic Injectables Product Portfolio, Specification and Application
3.7.3 Grifols Generic Injectables Revenue and Gross Margin (2019-2021)
3.7.4 Hikma Pharmaceuticals PLC Key Development
3.9 Fresenius Kabi
3.9.1 Fresenius Kabi Company Information
3.9.2 Fresenius Kabi Generic Injectables Product Portfolio, Specification and Application
3.9.3 Fresenius Kabi Generic Injectables Revenue and Gross Margin (2019-2021)
3.9.4 Fresenius Kabi Key Development
3.8 Gland Pharma
3.8.1 Gland Pharma Company Information
3.8.2 Gland Pharma Generic Injectables Product Portfolio, Specification and Application
3.8.3 Gland Pharma Generic Injectables Revenue and Gross Margin (2019-2021)
3.8.4 Gland Pharma Key Development
3.11 Dr. Reddy's Laboratories Ltd
3.11.1 Dr. Reddy's Laboratories Ltd Company Information
3.11.2 Dr. Reddy's Laboratories Ltd Generic Injectables Product Portfolio, Specification and Application
3.11.3 Dr. Reddy's Laboratories Ltd Generic Injectables Revenue and Gross Margin (2019-2021)
3.11.4 Dr. Reddy's Laboratories Ltd Key Development
3.12 Auromedics
3.12.1 Auromedics Company Information
3.12.2 Auromedics Generic Injectables Product Portfolio, Specification and Application
3.12.3 Auromedics Generic Injectables Revenue and Gross Margin (2019-2021)
3.12.4 Auromedics Key Development
13 Global Generic Injectables Market Forecast by Region by Type and by Application
13.1 Global Generic Injectables Revenue Forecast 2022-2027
13.2 Global Generic Injectables Forecast by Regions
13.3 Global Generic Injectables Forecast by Type
13.4 Global Generic Injectables Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Generic Injectables Production Specifications
Table 2: Drivers in Generic Injectables Market
Table 3: Restraints Generic Injectables Market
Table 4: Opportunity in Generic Injectables Market
Table 5: Comparion of Alternative and Generic Injectables
Table 6: Generic Injectables Raw Materials Key Suppliers List
Table 7: Generic Injectables Distributors List
Table 8: Generic Injectables Major Buyers in Application One
Table 9: Generic Injectables Major Buyers in Application Two
Table 10: Generic Injectables Major Buyers in Application Three
Table 11: Global Generic Injectables Revenue (Million USD) by Type 2016-2021
Table 12: Global Generic Injectables Revenue Market Share by Type 2016-2021
Table 18: Global Generic Injectables Revenue (Million USD) by Application 2016-2021
Table 19: Global Generic Injectables Revenue Market Share by Application 2016-2021
Table 20: Global Generic Injectables Revenue (Million USD) by Region 2016-2021
Table 21: Global Generic Injectables Revenue Market Share by Region 2016-2021
Table 22: North America Generic Injectables Revenue (Million USD) by Country 2016-2021
Table 23: North America Generic Injectables Revenue Market Share by Country 2016-2021)
Table 24: Europe Generic Injectables Revenue (Million USD) by Country 2016-2021
Table 25: Europe Generic Injectables Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Generic Injectables Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Generic Injectables Revenue Market Share by Country 2016-2021)
Table 28: South America Generic Injectables Revenue (Million USD) by Country 2016-2021
Table 29: South America Generic Injectables Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Generic Injectables Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Generic Injectables Revenue Market Share by Country 2016-2021)
Table 32 Teva Pharmaceutical Company Information
Table 33 Teva Pharmaceutical Generic Injectables Product Portfolio, Specification and Application
Table 34 Teva Pharmaceutical Generic Injectables Revenue and Gross Margin (2019-2021)
Table 35 Sanofi Company Information
Table 36 Sanofi Generic Injectables Product Portfolio, Specification and Application
Table 37 Sanofi Generic Injectables Revenue and Gross Margin (2019-2021)
Table 38 Sandoz (Novartis) Company Information
Table 39 Sandoz (Novartis) Generic Injectables Product Portfolio, Specification and Application
Table 40 Sandoz (Novartis) Generic Injectables Revenue and Gross Margin (2019-2021)
Table 41 Nichi-Iko Group (Sagent) Company Information
Table 42 Nichi-Iko Group (Sagent) Generic Injectables Product Portfolio, Specification and Application
Table 43 Nichi-Iko Group (Sagent) Generic Injectables Revenue and Gross Margin (2019-2021)
Table 44 Hospira (Pfizer Inc.) Company Information
Table 45 Hospira (Pfizer Inc.) Generic Injectables Product Portfolio, Specification and Application
Table 46 Hospira (Pfizer Inc.) Generic Injectables Revenue and Gross Margin (2019-2021)
Table 47 Hikma Pharmaceuticals PLC Company Information
Table 48 Hikma Pharmaceuticals PLC Generic Injectables Product Portfolio, Specification and Application
Table 49 Hikma Pharmaceuticals PLC Generic Injectables Revenue and Gross Margin (2019-2021)
Table 50 Grifols Company Information
Table 51 Grifols Generic Injectables Product Portfolio, Specification and Application
Table 52 Grifols Generic Injectables Revenue and Gross Margin (2019-2021)
Table 53 Gland Pharma Company Information
Table 54 Gland Pharma Generic Injectables Product Portfolio, Specification and Application
Table 55 Gland Pharma Generic Injectables Revenue and Gross Margin (2019-2021)
Table 56 Fresenius Kabi Company Information
Table 57 Fresenius Kabi Generic Injectables Product Portfolio, Specification and Application
Table 58 Fresenius Kabi Generic Injectables Revenue and Gross Margin (2019-2021)
Table 59: Global Generic Injectables Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Generic Injectables Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Generic Injectables Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Generic Injectables Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Generic Injectables Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Generic Injectables Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Generic Injectables Picture
Figure 2: Global Generic Injectables Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Generic Injectables Industry Life Cycle
Figure 5: Product Picture of Small Molecule
Figure 6: Product Picture of Large Molecule
Figure 9: Global Generic Injectables Revenue Market Share by Type, 2020
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets